SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Why Houseplant Canada ≠ Houseplant USA

    By

    Rogen brings his talents to California 

    Seth Rogen, Canada’s most famous stoner, and long-time collaborator Evan Goldberg are launching their cannabis brand Houseplant in the US. “We are finally ready to launch in America,” Rogen said in a video on Twitter.

    Why should you care?

    Canadians are already familiar with the Canopy brand, which launched in 2019 with riffs on mid-century modern design. But nearly everything else sounds distinct from the Canadian version, making its earlier launch in Canada look kind of like a test run. 

    Are there differences between Canadian and US Houseplants? 

    In short, yes. Rogen can actually promote the product to the US market, something that’s not allowed under Canada’s Cannabis Act. The packaging is tin instead of plastic. And, importantly, the cannabis on offer isn’t the same: Houseplant Canada’s sativa is Chemdog and Houseplant’s US sativa is called Pancake Ice. Also important to note, Rogen said on Twitter. “It’s over 33% THC.”

    Canadians, avert your eyes

    Because it’s (kind of) a crossborder brand, here’s an unwieldy disclaimer instructing Canadians to ignore the US website… “Notice to Canada residents. This site is intended for and directed to users and customers in the United States of America. If you are in Canada, please visit us at www.houseplant.ca.”


    What’s next?

    Next week, shoppers can buy House Goods from anywhere in the US, and Californians can actually buy the 3 strains on Houseplant.com.


    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    BofC

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free